Ankyrin Repeat Domain 1 Overexpression is Associated with Common Resistance to Afatinib and Osimertinib in EGFR-mutant Lung Cancer-Reference-Cited by-同舟云学术

Ankyrin Repeat Domain 1 Overexpression is Associated with Common Resistance to Afatinib and Osimertinib in EGFR-mutant Lung Cancer

Published:2018-10-05 Issue:1 Volume:8 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Takahashi Akiko,Seike Masahiro,Chiba Mika,Takahashi Satoshi,Nakamichi Shinji,Matsumoto Masaru,Takeuchi Susumu,Minegishi Yuji,Noro Rintaro,Kunugi Shinobu,Kubota Kaoru,Gemma Akihiko

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-018-33190-8.pdf

Reference45 articles.

1. Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2016. CA: a cancer journal for clinicians 66, 7–30, https://doi.org/10.3322/caac.21332 (2016).

2. Tsao, A. S. et al. Scientific Advances in Lung Cancer 2015. Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer 11, 613–638, https://doi.org/10.1016/j.jtho.2016.03.012 (2016).

3. Hirsch, F. R. et al. Lung cancer: current therapies and new targeted treatments. Lancet (London, England) 389, 299–311, https://doi.org/10.1016/s0140-6736(16)30958-8 (2017).

4. Lynch, T. J. et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. The New England journal of medicine 350, 2129–2139, https://doi.org/10.1056/NEJMoa040938 (2004).

5. Paez, J. G. et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science (New York, N.Y.) 304, 1497–1500, https://doi.org/10.1126/science.1099314 (2004).

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chitinase 3-like-1 (CHI3L1) in the pathogenesis of epidermal growth factor receptor mutant non-small cell lung cancer;Translational Oncology;2024-11

2. Defective N-glycosylation of IL6 induces metastasis and tyrosine kinase inhibitor resistance in lung cancer;Nature Communications;2024-09-09

3. CD44-hyaluronan mediating endocytosis of iron-platinum alloy nanoparticles induces ferroptotic cell death in mesenchymal-state lung cancer cells with tyrosine kinase inhibitor resistance;Acta Biomaterialia;2024-09

4. CASQ2 alleviates lung cancer by inhibiting M2 tumor‐associated macrophage polarization and JAK/STAT pathway;Journal of Biochemical and Molecular Toxicology;2024-08

5. Dysregulated gene subnetworks in breast invasive carcinoma reveal novel tumor suppressor genes;Scientific Reports;2024-07-08